(VIANEWS) – Harmony Biosciences Holdings (HRMY), Amtech Systems (ASYS), Walt Disney (DIS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Harmony Biosciences Holdings (HRMY)
33.3% sales growth and 57.63% return on equity
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy in the United States. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Earnings Per Share
As for profitability, Harmony Biosciences Holdings has a trailing twelve months EPS of $3.06.
PE Ratio
Harmony Biosciences Holdings has a trailing twelve months price to earnings ratio of 11.24. Meaning, the purchaser of the share is investing $11.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 57.63%.
Yearly Top and Bottom Value
Harmony Biosciences Holdings’s stock is valued at $34.39 at 06:22 EST, way under its 52-week high of $62.08 and way above its 52-week low of $29.81.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 64.1% and a drop 52.8% for the next.
2. Amtech Systems (ASYS)
20.7% sales growth and 16.03% return on equity
Amtech Systems, Inc. manufactures and sells capital equipment and related consumables for use in fabricating silicon carbide (SiC), silicon power devices, analog and discrete devices, electronic assemblies, and light-emitting diodes (LEDs) worldwide. The company operates in Semiconductor; and Material and Substrate segments. The Semiconductor segment designs, manufactures, sells, and services thermal processing equipment, including solder reflow ovens, horizontal diffusion furnaces, and custom high-temp belt furnaces for use by semiconductor, electronics, and electro/mechanical assembly manufacturers, as well as automotive and other industries; and diffusion and reflow thermal systems, as well as wafer polishing equipment and related services. The Material and Substrate segment manufactures and sells consumables and machinery for lapping and polishing of materials, such as silicon wafers for semiconductor products; sapphire substrates for LED lighting and mobile devices; silicon carbide wafers for LED and power device applications; various glass and silica components for 3D image transmission; quartz and ceramic components for telecommunications devices; and medical device components, and optical and photonics applications. This segment also offers substrate process chemicals for use in various manufacturing processes, including semiconductors, silicon and compound semiconductor wafers, and optics. The company sells its products through sales personnel, as well as a network of independent sales representatives and distributors. The company was formerly known as Quartz Engineering & Materials, Inc. and changed its name to Amtech Systems, Inc. in 1987. Amtech Systems, Inc. was incorporated in 1981 and is headquartered in Tempe, Arizona.
Earnings Per Share
As for profitability, Amtech Systems has a trailing twelve months EPS of $1.07.
PE Ratio
Amtech Systems has a trailing twelve months price to earnings ratio of 8.73. Meaning, the purchaser of the share is investing $8.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.
3. Walt Disney (DIS)
7.7% sales growth and 4.3% return on equity
The Walt Disney Company, together with its subsidiaries, operates as an entertainment company worldwide. It operates through two segments, Disney Media and Entertainment Distribution; and Disney Parks, Experiences and Products. The company engages in the film and episodic television content production and distribution activities, as well as operates television networks under the ABC, Disney, ESPN, Freeform, FX, Fox, National Geographic, and Star brands; and studios that produces films under the Walt Disney Pictures, Twentieth Century Studios, Marvel, Lucasfilm, Pixar, and Searchlight Pictures banners. It also offers direct-to-consumer streaming services through Disney+, Disney+ Hotstar, ESPN+, Hulu, and Star+; sale/licensing of film and television content to third-party television and subscription video-on-demand services; theatrical, home entertainment, and music distribution services; staging and licensing of live entertainment events; and post-production services by Industrial Light & Magic and Skywalker Sound. In addition, the company operates theme parks and resorts, such as Walt Disney World Resort in Florida; Disneyland Resort in California; Disneyland Paris; Hong Kong Disneyland Resort; and Shanghai Disney Resort; Disney Cruise Line, Disney Vacation Club, National Geographic Expeditions, and Adventures by Disney, as well as Aulani, a Disney resort and spa in Hawaii. Further, it licenses its intellectual property to a third party for the operations of the Tokyo Disney Resort; provides consumer products, including licensing of trade names, characters, visual, literary, and other IP for use on merchandise, published materials, and games; operates a direct-to-home satellite distribution platform; sells branded merchandise through retail, online, and wholesale businesses; and develops and publishes books, comic books, and magazines. The Walt Disney Company was founded in 1923 and is based in Burbank, California.
Earnings Per Share
As for profitability, Walt Disney has a trailing twelve months EPS of $2.27.
PE Ratio
Walt Disney has a trailing twelve months price to earnings ratio of 40.12. Meaning, the purchaser of the share is investing $40.12 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.3%.
Yearly Top and Bottom Value
Walt Disney’s stock is valued at $91.07 at 06:22 EST, way below its 52-week high of $126.48 and above its 52-week low of $84.07.
4. AptarGroup (ATR)
7.1% sales growth and 11.23% return on equity
AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active packaging products. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. The company sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. AptarGroup, Inc. has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. The company was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Earnings Per Share
As for profitability, AptarGroup has a trailing twelve months EPS of $3.49.
PE Ratio
AptarGroup has a trailing twelve months price to earnings ratio of 34.09. Meaning, the purchaser of the share is investing $34.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.23%.
Yearly Top and Bottom Value
AptarGroup’s stock is valued at $118.99 at 06:22 EST, under its 52-week high of $122.50 and way above its 52-week low of $90.23.
Volume
Today’s last reported volume for AptarGroup is 91916 which is 58.38% below its average volume of 220864.
Earnings Before Interest, Taxes, Depreciation, and Amortization
AptarGroup’s EBITDA is 2.66.
5. National Health Investors (NHI)
6% sales growth and 6.58% return on equity
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Earnings Per Share
As for profitability, National Health Investors has a trailing twelve months EPS of $2.09.
PE Ratio
National Health Investors has a trailing twelve months price to earnings ratio of 25.12. Meaning, the purchaser of the share is investing $25.12 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.58%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 89.4% and 17.9%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15%, now sitting on 289.53M for the twelve trailing months.
6. Zoetis (ZTS)
5.6% sales growth and 45.21% return on equity
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Earnings Per Share
As for profitability, Zoetis has a trailing twelve months EPS of $4.42.
PE Ratio
Zoetis has a trailing twelve months price to earnings ratio of 38.98. Meaning, the purchaser of the share is investing $38.98 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 45.21%.
